東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

The Impact of the COVID-19 Pandemic on the Healthcare of Patients with Type 2 Diabetes Mellitus in the Department of Veterans Affairs.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The Impact of the COVID-19 Pandemic on the Healthcare of Patients with Type 2 Diabetes Mellitus in the Department of Veterans Affairs./
作者:	Viernes, Benjamin Forrest.
面頁冊數:	1 online resource (96 pages)
附註:	Source: Dissertations Abstracts International, Volume: 84-08, Section: B.
Contained By:	Dissertations Abstracts International84-08B.
標題:	Epidemiology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30242002click for full text (PQDT)
ISBN:	9798374416961

The Impact of the COVID-19 Pandemic on the Healthcare of Patients with Type 2 Diabetes Mellitus in the Department of Veterans Affairs.
Viernes, Benjamin Forrest.

The Impact of the COVID-19 Pandemic on the Healthcare of Patients with Type 2 Diabetes Mellitus in the Department of Veterans Affairs. - 1 online resource (96 pages)

Source: Dissertations Abstracts International, Volume: 84-08, Section: B.

Thesis (Ph.D.)--The University of Utah, 2022.

Includes bibliographical references

The novel coronavirus (COVID-19) pandemic and strategies meant to mitigate infections caused disruptions to healthcare services across the globe. To evaluate the impact of the COVID-19 pandemic on the healthcare of patients with type 2 diabetes in the VA healthcare system, this work enumerated a cohort of patients with type 2 diabetes who utilized care in the VA across all months between March 2018 and February 2022 and analyzed service utilization, medication adherence, and diabetes-related short-term outcomes.The first objective was to determine the effect of the pandemic's interruption on the utilization of diabetes-related outpatient encounters. Results showed that the share of patients with diabetes with at least one virtual care visit increased from 3.4% in the pre- COVID year (March 2019 to February 2020) to 16.4% in the first year during COVID (March 2020 to February 2021) while the percent of patients with diabetes with an in- person diabetes-related outpatient visit fell from 89.8% to 72.3%.Second, large changes in oral antidiabetic medication use, adherence (i.e., proportion of days (PDC) covered ≥80%), and discontinuation (zero days covered) were discovered during the pandemic among patients with treated type 2 diabetes. The mean percent adherent was 23.4%, 11.6%, and 30.1% during the pre-pandemic (i.e., March 2018-February 2020), pre-vaccine pandemic (i.e., March 2020-December 2020), and post-vaccine pandemic (i.e., January 2021-February 2020) periods, respectively.Finally, this study evaluated changes in average A1C measurement, glycemic control, and preventable diabetes outcomes before and during the COVID-19 pandemic. The percent of eligible patients with A1C measurement decreased by 8.6% when the pandemic began, trending back to pre-pandemic levels by January 2021, at which point it fell by about 1% per month to end of study. The rate of uncontrolled diabetes averaged 400 per 100,000 before the pandemic, but rose to almost 550 per 100,000 patients during the pandemic. Likewise, the rate of short-term complications averaged 30 per 100,000, but rose to 49 per 100,000 at its high during the pandemic.The pandemic's interruptions caused vast differences in the healthcare routines of patients with diabetes, which initially led to more negative outcomes than before the pandemic.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798374416961Subjects--Topical Terms:

568544
Epidemiology.
Subjects--Index Terms:

COVID-19Index Terms--Genre/Form:

542853
Electronic books.

The Impact of the COVID-19 Pandemic on the Healthcare of Patients with Type 2 Diabetes Mellitus in the Department of Veterans Affairs.
LDR:03837nmm a2200433K 4500 001 2365727
005 20231218204651.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798374416961
035 $a (MiAaPQ)AAI30242002
035 $a AAI30242002
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Viernes, Benjamin Forrest. $3 3706596
245 1 4 $a The Impact of the COVID-19 Pandemic on the Healthcare of Patients with Type 2 Diabetes Mellitus in the Department of Veterans Affairs.
264 0 $c 2022
300 $a 1 online resource (96 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 84-08, Section: B.
500 $a Advisor: Pugh, Mary Jo.
502 $a Thesis (Ph.D.)--The University of Utah, 2022.
504 $a Includes bibliographical references
520 $a The novel coronavirus (COVID-19) pandemic and strategies meant to mitigate infections caused disruptions to healthcare services across the globe. To evaluate the impact of the COVID-19 pandemic on the healthcare of patients with type 2 diabetes in the VA healthcare system, this work enumerated a cohort of patients with type 2 diabetes who utilized care in the VA across all months between March 2018 and February 2022 and analyzed service utilization, medication adherence, and diabetes-related short-term outcomes.The first objective was to determine the effect of the pandemic's interruption on the utilization of diabetes-related outpatient encounters. Results showed that the share of patients with diabetes with at least one virtual care visit increased from 3.4% in the pre- COVID year (March 2019 to February 2020) to 16.4% in the first year during COVID (March 2020 to February 2021) while the percent of patients with diabetes with an in- person diabetes-related outpatient visit fell from 89.8% to 72.3%.Second, large changes in oral antidiabetic medication use, adherence (i.e., proportion of days (PDC) covered ≥80%), and discontinuation (zero days covered) were discovered during the pandemic among patients with treated type 2 diabetes. The mean percent adherent was 23.4%, 11.6%, and 30.1% during the pre-pandemic (i.e., March 2018-February 2020), pre-vaccine pandemic (i.e., March 2020-December 2020), and post-vaccine pandemic (i.e., January 2021-February 2020) periods, respectively.Finally, this study evaluated changes in average A1C measurement, glycemic control, and preventable diabetes outcomes before and during the COVID-19 pandemic. The percent of eligible patients with A1C measurement decreased by 8.6% when the pandemic began, trending back to pre-pandemic levels by January 2021, at which point it fell by about 1% per month to end of study. The rate of uncontrolled diabetes averaged 400 per 100,000 before the pandemic, but rose to almost 550 per 100,000 patients during the pandemic. Likewise, the rate of short-term complications averaged 30 per 100,000, but rose to 49 per 100,000 at its high during the pandemic.The pandemic's interruptions caused vast differences in the healthcare routines of patients with diabetes, which initially led to more negative outcomes than before the pandemic.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Epidemiology. $3 568544
650 4 $a Medicine. $3 641104
650 4 $a Public health. $3 534748
653 $a COVID-19
653 $a Diabetes
653 $a Health services research
653 $a Veterans affairs
653 $a Healthcare
653 $a Patients
653 $a Type 2 diabetes mellitus
653 $a Impact
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0766
690 $a 0564
690 $a 0573
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a The University of Utah. $b Population Health Sciences. $3 3706597
773 0 $t Dissertations Abstracts International $g 84-08B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30242002 $z click for full text (PQDT)